Filter News
Area of Research
News Type
News Topics
- (-) Chemical Sciences (3)
- (-) Coronavirus (10)
- 3-D Printing/Advanced Manufacturing (6)
- Advanced Reactors (1)
- Artificial Intelligence (6)
- Big Data (2)
- Bioenergy (7)
- Biology (7)
- Biomedical (14)
- Biotechnology (1)
- Clean Water (2)
- Composites (1)
- Computer Science (13)
- Cybersecurity (1)
- Energy Storage (6)
- Environment (8)
- Fossil Energy (1)
- Frontier (1)
- Fusion (1)
- High-Performance Computing (2)
- Hydropower (1)
- Machine Learning (3)
- Materials (14)
- Materials Science (23)
- Mathematics (1)
- Microscopy (3)
- Nanotechnology (10)
- National Security (2)
- Neutron Science (120)
- Nuclear Energy (3)
- Physics (9)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (7)
- Security (2)
- Space Exploration (3)
- Summit (6)
- Transportation (5)
ORNL's Communications team works with news media seeking information about the laboratory. Media may use the resources listed below or send questions to news@ornl.gov.
1 - 10 of 13 Results

Scientists at ORNL used neutrons to end a decades-long debate about an enzyme cancer uses.

A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.

Researchers from Yale University and ORNL collaborated on neutron scattering experiments to study hydrogen atom locations and their effects on iron in a compound similar to those commonly used in industrial catalysts.

An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.

At the Department of Energy’s Oak Ridge National Laboratory, scientists use artificial intelligence, or AI, to accelerate the discovery and development of materials for energy and information technologies.

Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.

Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.

To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.

A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.

COVID-19 has upended nearly every aspect of our daily lives and forced us all to rethink how we can continue our work in a more physically isolated world.